Nucleai
Elad Amsalem's work experience includes being the Director of Engineering at Nucleai starting in October 2022. Prior to this, they worked at AppFront where they held the positions of VP R&D from May 2018 to October 2022, and Head of Apps from October 2017 to October 2022. Before AppFront, Elad worked as a Software Engineering Consultant at dapulse from August 2016 to May 2017, and at SpacePharma from April 2015 to January 2017.
From 2002 to 2005, Elad Amsalem attended Tel Aviv University, where they earned a Bachelor of Science (BSc) degree in Electrical and Electronics Engineering.
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.